---
title: "CLSA Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296660775.md"
description: "In a report released yesterday, from CLSA maintained a Buy rating on CSPC Pharmaceutical Group, with a price target of HK$19.00.Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In a report released yesterday, Citi also maintained a Buy rating on the stock with a HK$14.00 price target."
datetime: "2026-08-22T00:26:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296660775.md)
  - [en](https://longbridge.com/en/news/296660775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296660775.md)
generator: "portal-rs"
---

# CLSA Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)

In a report released yesterday, from CLSA maintained a Buy rating on CSPC Pharmaceutical Group, with a price target of HK$19.00.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In a report released yesterday, Citi also maintained a Buy rating on the stock with a HK$14.00 price target.

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [CSPC PHARMA  1H26 Net Profit Surges Nearly 1.4x, Interim DPS Up 28.6% to HKD0.18](https://longbridge.com/en/news/296435690.md)
- [CSPC Pharma FY26 H1 profit attributable to shareholders more than doubled to RMB 6.09 billion; revenue rises 40.1% to RMB 18.59 billion](https://longbridge.com/en/news/296433558.md)
- [M Stanley Raises CSPC PHARMA  TP to HKD12, Rating Overweight](https://longbridge.com/en/news/296557755.md)
- [CICC Keeps Their Buy Rating on J&T Global Express Limited (1519)](https://longbridge.com/en/news/296693029.md)
- [Goldman Sachs Keeps Their Hold Rating on Weibo (WB)](https://longbridge.com/en/news/296494184.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**